Skyhawk Therapeutics Stock

skyhawktx.comHealthcare / BioTech & PharmaFounded: 2015

Skyhawk Therapeutics, founded in 2016, is a biotechnology company with the aim of discovering, developing, and commercializing innovative therapies utilizing its novel SkySTARTM (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) platform. By harnessing the power of RNA-targeting technology, Skyhawk Therapeutics strives to address unmet medical needs and bring transformative therapies to market. Skyhawk Therapeutics is headquartered in Waltham, Massachusetts.

Register To Buy and Sell Shares

For more details on financing and valuation for Skyhawk Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Skyhawk Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Skyhawk Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Kathleen McCarthy
Co-Founder & Chief Scientific Officer
Sergey Paushkin Ph.D
Senior Vice President, Discovery Biology
Maura McCarthy
Senior Vice President, Corporate Development
William Haney
Co-Founder, Chief Executive Officer & Chairman
Clinton Musil
Chief Financial Officer

Frequently Asked Questions About Skyhawk Therapeutics’ Stock

Can you buy Skyhawk Therapeutics’ stock?
Skyhawk Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Skyhawk Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Skyhawk Therapeutics’ stock?
Yes, you can sell stock of a private company like Skyhawk Therapeutics. Forge can help you sell your Skyhawk Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Skyhawk Therapeutics’ stock price?
Skyhawk Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Skyhawk Therapeutics’ private market stock price with Forge Data.
What is Skyhawk Therapeutics’ stock ticker symbol?
Skyhawk Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Skyhawk’s RNA splicing modifier for Huntington’s disease cleared for Australian trial
Skyhawk Therapeutics Inc. has received approval from the Australian human research ethic committee (HREC) to begin a phase I trial of its SKY-0515 treatment for Huntington’s disease.
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.